
Aerospace and defense company Ducommun (NYSE:DCO) will be reporting results this Tuesday before the bell. Here’s what investors should know.
Ducommun missed analysts’ revenue expectations last quarter, reporting revenues of $215.8 million, up 9.4% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ EBITDA estimates and a solid beat of analysts’ adjusted operating income estimates.
Is Ducommun a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Ducommun’s revenue to grow 2.7% year on year, in line with the 1.7% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Ducommun rarely misses Wall Street’s revenue estimates.
Looking at Ducommun’s peers in the aerospace segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Rocket Lab delivered year-on-year revenue growth of 63.5%, beating analysts’ expectations by 4.9%, and Howmet reported revenues up 19.1%, topping estimates by 3.2%. Rocket Lab traded up 33% following the results while Howmet was also up 5.5%.
Read our full analysis of Rocket Lab’s results here and Howmet’s results here.
There has been positive sentiment among investors in the aerospace segment, with share prices up 3.5% on average over the last month. Ducommun is down 2.6% during the same time and is heading into earnings with an average analyst price target of $146.60 (compared to the current share price of $137.39).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.